Pharma Companies Race to Tackle COVID-19

Since the novel coronavirus started to spread globally, a mix of legacy pharmaceutical companies and small startups have been scrambling to develop a treatment or vaccine for COVID-19, the disease caused by the virus. While developing a vaccine would take at least 12 to 18 months, drugmakers and researchers are testing existing medications used for other illnesses as potential treatments.

© 2023 MMIT
Freelance Reporter

Freelance Reporter Freelance Reporter

Related Posts

pharmacists
September 14

‘Delinking’ PBM Pay From Drug Prices Comes With High Cost, Economist Argues

READ MORE
capitol-dome
September 14

House Committees Proffer Modest PBM Reform Bill

READ MORE
blurry-judge
September 14

Legal Challenges to Drug Price Negotiations Could Have Broad Implications

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today